Jane Street Group, LLC Spring Works Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 81,652 shares of SWTX stock, worth $4.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,652

Previous 222,777 63.35%

Holding current value

$4.41 Million

Previous $8.39 Million 68.83%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $4.52 Million - $6.03 Million	-141,125 Reduced 63.35%	81,652 $2.62 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $12.9 Million - $17.1 Million	-358,161 Reduced 61.65%	222,777 $8.39 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $16.8 Million - $24.1 Million	459,342 Added 377.76%	580,938 $28.6 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $1.58 Million - $3.11 Million	83,392 Added 218.28%	121,596 $4.44 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $4.73 Million - $6.42 Million	-204,558 Reduced 84.26%	38,204 $883,000
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $4.36 Million - $6.16 Million	188,314 Added 345.86%	242,762 $6.37 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $1.36 Million - $1.85 Million	54,448 New	54,448 $1.4 Million
Q2 2022 Aug 16, 2022	SELL	$18.36 - $60.07 $188,612 - $617,099	-10,273 Reduced 31.64%	22,196 $547,000
Q1 2022 May 17, 2022	BUY	$48.97 - $65.46 $709,820 - $948,842	14,495 Added 80.64%	32,469 $1.83 Million
Q4 2021 Feb 15, 2022	SELL	$53.3 - $75.84 $154,143 - $219,329	-2,892 Reduced 13.86%	17,974 $1.11 Million
Q3 2021 Nov 16, 2021	BUY	$62.66 - $88.26 $1.31 Million - $1.84 Million	20,866 New	20,866 $1.32 Million
Q4 2020 Feb 17, 2021	SELL	$48.36 - $77.92 $1.38 Million - $2.23 Million	-28,573 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$36.14 - $51.99 $718,390 - $1.03 Million	19,878 Added 228.61%	28,573 $1.36 Million
Q2 2020 Aug 17, 2020	BUY	$22.98 - $48.57 $199,811 - $422,316	8,695 New	8,695 $365,000
Q4 2019 Feb 14, 2020	SELL	$17.74 - $39.52 $250,879 - $558,891	-14,142 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $265,869 - $393,430	14,142 New	14,142 $307,000

Others Institutions Holding SWTX

# of Institutions

241

Shares Held

70.1M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.37B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Spring Works Therapeutics, Inc. Transaction History